Clariane

Expecting a smaller dilution effect

08/05/24 -"We have maintained our assumptions based on the company's planned €300m recap to be completed by the end of this year, but with an expected subscription price now adjusted up from €1.52 to €1.93 ..."

PDF page sample
Pages
66
Language
English
Published on
08/05/24
Download
You may also be interested by these reports :
24/05/24
Besides the improving end markets and the better/newer products being launched, the firm’s tangible progress on its strategic initiatives including: ...
22/05/24
We have obtained more details and feedback after attending Clariane’s Capital Market Day and discussing with several senior managers. The company’s ...
21/05/24
Following the release of reassuring-looking terms for the long-awaited recaps and steady progress on asset disposals, Clariane can now refocus on its ...
17/05/24
Clariane communicated more details regarding its projected capital increases and the entry of a new anchor shareholder in its capital. We take this ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO